Abstract
Purpose
The purpose of this study was to investigate the adequacy of hypertension management in hypertensive elderly living in long-term-care facilities compared with home-living elderly.
Methods
This retrospective, cross-sectional, pharmacoepidemiological study compared data from a community-dwelling population (CD) and from four nursing homes (NH) in Dresden, Germany. Individuals aged ≥65 with the diagnosis of arterial hypertension were included. Demographical, medical, and drug prescription data as well as blood pressure (BP) values were analyzed and compared descriptively after matching the populations by age and gender.
Results
Each population comprised 209 patients (mean age 80.4 years [±6], 70.3% women). NH showed a higher number of diseases [7 (5–9) vs. 5 (3–7); p < 0.001]. BP (<140/90 mmHg) was better controlled in NH (61.0% vs. 48.1%; p = 0.015). The median number of BP-lowering drugs was three (2–4; CD) and two (1–3; NH) (range: 0–9). Most frequently used antihypertensives were diuretics and beta-blockers. Among renin–angiotensin system (RAS) blockers, angiotensin-receptor blockers (ARBs) were preferred in CD and angiotensin-converting enzyme (ACE) inhibitors in NH. Drug treatment for secondary prevention of myocardial infarction or stroke [acetylsalicylic acid (ASA) 100, RAS-blocker, beta-blocker, statin] was low among both groups (CD 21.3%; NH 1.6%; p = 0.01). NH received more inappropriate drugs, especially tranquillizers (31.2% vs. 21.0%; p < 0.05) [according to the PRISCUS (Latin for “old and venerable”) list for potentially inappropriate medications in the elderly (PIM)].
Conclusions
NH residents showed better BP control than CD elderly while receiving less antihypertensive drugs. The prescription of antihypertensives was assumed to be more cost effective in NH. Nevertheless, inappropriate drug use is still high (NH > CD), and there is an extended need for professional medication assessment in both groups of elderly.
Similar content being viewed by others
References
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360(9349):1903–1913. doi:10.1016/S0140-6736(02)11911-8
Manson JE, Tosteson H, Ridker PM, Satterfield S, Hebert P, O’Connor GT, Buring JE, Hennekens CH (1992) The primary prevention of myocardial infarction. N Engl J Med 326(21):1406–1416
Straus SE, Majumdar SR, McAlister FA (2002) New evidence for stroke prevention: scientific review. Jama 288(11):1388–1395. doi:10.1001/jama.288.11.1388
Whitworth JA (2003) 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21(11):1983–1992
Logan AG (2011) Hypertension in aging patients. Expert Rev Cardiovasc Ther 9(1):113–120. doi:10.1586/erc.10.171
Herrlinger C, Klotz U (2001) Drug metabolism and drug interactions in the elderly. Best Pract Res Clin Gastroenterol 15(6):897–918. doi:10.1053/bega.2001.0249
Bolbrinker J, Schedensack G, Kolzsch M, Breckwoldt J, Arntz HR, Kreutz R (2009) Antihypertensive drug treatment and renal function in geriatric emergency patients. Dtsch Med Wochenschr 134(16):802–806. doi:10.1055/s-0029-1220233
Tulner LR, Frankfort SV, Gijsen GJ, van Campen JP, Koks CH, Beijnen JH (2008) Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance. Drugs Aging 25(4):343–355
Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW (2005) Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. Jama 294(6):716–724. doi:10.1001/jama.294.6.716
Kreutz R (2009) Special features of pharmacotherapy in older hypertensive subjects. Internist (Berl). doi:10.1007/s00108-008-2293-7
McDonald M, Hertz RP, Unger AN, Lustik MB (2009) Prevalence, awareness, and management of hypertension, dyslipidemia, and diabetes among United States adults aged 65 and older. J Gerontol A Biol Sci Med Sci 64(2):256–263. doi:10.1093/gerona/gln016
Muller A, Schweizer J, Kirch W, Schindler C (2010) Current status of antihypertensive drug treatment in primary care practice at launch of the new renin inhibitor aliskiren (RASANT). Med Klin (Munich) 105(3):155–162. doi:10.1007/s00063-010-1025-7
Peron EP, Marcum ZA, Boyce R, Hanlon JT, Handler SM (2011) Year in review: medication mishaps in the elderly. Am J Geriatr Pharmacother 9(1):1–10. doi:10.1016/j.amjopharm.2011.01.003
Uhrhan T, Schaefer M (2010) Drug supply and patient safety in long-term care facilities for the elderly. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 53(5):451–459. doi:10.1007/s00103-010-1053-8
Kolzsch M, Bolbrinker J, Drager D, Scholze J, Huber M, Kreutz R (2010) Prescribing of antihypertensive drugs to elderly residents of nursing homes in Germany. Dtsch Med Wochenschr 135(48):2400–2405. doi:10.1055/s-0030-1269407
Stergiou GS, Bliziotis IA (2011) Home Blood Pressure Monitoring in the Diagnosis and Treatment of Hypertension: A Systematic Review. Am J Hypertens 24:123–134. doi:10.1038/ajh.2010.194
World Health Organisation, Collaborating Centre for Drug Statistics Methodology (2011) ATC Index with DDDs. Oslo
Fulton MM, Allen ER (2005) Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract 17(4):123–132. doi:10.1111/j.1041-2972.2005.0020.x
Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, Meinow B, Fratiglioni L (2011) Aging with multimorbidity: A systematic review of the literature. Ageing Res Rev Epub ahead of print. doi:10.1016/j.arr.2011.03.003
Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome–a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23(5):469–480. doi:10.1111/j.1464-5491.2006.01858.x
World Health Organisation (March 2011) Obesity and overweight. WHO Fact sheet N°311. Accessed 28/04 2011
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O’Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B (2007) 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25(6):1105–1187. doi:10.1093/eurheartj/ehm236
Wald NJ, Law MR (2003) A strategy to reduce cardiovascular disease by more than 80%. Bmj 326(7404):1419. doi:10.1136/bmj.326.7404.1419
Holt S, Schmiedl S, Thürmann PA (2010) Potentially Inappropriate Medications in the Elderly: The PRISCUS List. Dtsch Arztebl Int 107(31–32):543–551. doi:10.3238/arztebl.2010.0543
Sharma AM, Wittchen HU, Kirch W, Pittrow D, Ritz E, Goke B, Lehnert H, Tschope D, Krause P, Hofler M, Pfister H, Bramlage P, Unger T (2004) High prevalence and poor control of hypertension in primary care: cross-sectional study. J Hypertens 22(3):479–486
Pittrow D, Kirch W, Bramlage P, Lehnert H, Hofler M, Unger T, Sharma AM, Wittchen HU (2004) Patterns of antihypertensive drug utilization in primary care. Eur J Clin Pharmacol 60(2):135–142. doi:10.1007/s00228-004-0731-6
Tsuyuki RT, McLean DL, McAlister FA (2008) Management of hypertension in elderly long-term care residents. Can J Cardiol 24(12):912–914. doi:10.1016/S0828-282X(08)70698-6
Cramer JA, Benedict A, Muszbek N, Keskinaslan A, Khan ZM (2008) The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract 62(1):76–87. doi:10.1111/j.1742-1241.2007.01630.x
Ho PM, Bryson CL, Rumsfeld JS (2009) Medication adherence: its importance in cardiovascular outcomes. Circulation 119(23):3028–3035. doi:10.1161/CIRCULATIONAHA.108.768986
Elliott WJ (2009) Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy. J Clin Hypertens (Greenwich) 11(7):376–382. doi:10.1111/j.1751-7176.2009.00138.x
Schwabe U, Pfaffrath D (2010) Arzneiverordnungs-Report 2010. Springer Berlin Heidelberg
Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C (2008) Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358(15):1547–1559. doi:10.1056/NEJMoa0801317
Schindler C (2008) ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist’s perspective after publication of the results of ONTARGET. Ther Adv Cardiovasc Dis 2(4):233–248. doi:10.1177/1753944708094309
Laux G, Szecsenyi J, Miksch A, Grun B, Gutscher A, Grun B, Rosemann T, Kuhlein T (2009) Antihypertensive pharmacotherapy of patients in primary care with either a statutory or private health insurance. Med Klin (Munich) 104(2):108–113. doi:10.1007/s00063-009-1028-4
Baumgart P (1993) Torasemide in comparison with thiazides in the treatment of hypertension. Cardiovasc Drugs Ther 7(Suppl 1):63–68
Wargo KA, Banta WM (2009) A comprehensive review of the loop diuretics: should furosemide be first line? Ann Pharmacother 43(11):1836–1847. doi:10.1345/aph.1M177
Luppa M, Luck T, Matschinger H, Konig HH, Riedel-Heller SG (2010) Predictors of nursing home admission of individuals without a dementia diagnosis before admission - results from the Leipzig Longitudinal Study of the Aged (LEILA 75+). BMC Health Serv Res 10(1):186. doi:10.1186/1472-6963-10-186
Coll-Planas L, Bergmann A, Schwarz P, Guillen-Grima F, Schulze J (2007) Quality of care among older adults with diabetes mellitus: comparison between community-dwelling adults attended to by home care services and nursing home residents in Dresden. Z Arztl Fortbild Qualitatssich 101(9):623–629. doi:10.1016/j.zgesun.2007.09.023
Hochdruckliga D, e.V. (2009) Leitlinien zur Behandlung der arteriellen Hypertonie. Nieren- und Hochdruckkrankheiten 38:137–188
Deutsche Hochdruckliga e.V. Kommission Diabetes Goal blood pressure in patients with diabetes (Report) from 2010 Sept 7.
Raum E, Lietzau S, Stegmaier C, Brenner H, Rothenbacher D (2008) For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany. Pharmacoepidemiol Drug Saf 17(5):485–494
Steinhagen-Thiessen E, Bramlage P, Losch C, Hauner H, Schunkert H, Vogt A, Wasem J, Jockel KH, Moebus S (2008) Dyslipidemia in primary care–prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol 7:31
Shanmugasundaram M, Rough SJ, Alpert JS (2010) Dyslipidemia in the elderly: should it be treated? Clin Cardiol 33(1):4–9
Bohler S, Scharnagl H, Freisinger F, Stojakovic T, Glaesmer H, Klotsche J, Pieper L, Pittrow D, Kirch W, Schneider H, Stalla GK, Lehnert H, Zeiher AM, Silber S, Koch U, Ruf G, Marz W, Wittchen HU (2007) Unmet needs in the diagnosis and treatment of dyslipidemia in the primary care setting in Germany. Atherosclerosis 190(2):397–407
Parikh S, Shrank WH, Mogun H, Choudhry NK (2010) Statin utilization in nursing home patients after cardiac hospitalization. J Gen Intern Med 25(12):1293–1299
Forman DE, Rich MW, Alexander KP, Zieman S, Maurer MS, Najjar SS, Cleveland JC Jr, Krumholz HM, Wenger NK (2011) Cardiac care for older adults. Time for a new paradigm. J Am Coll Cardiol 57(18):1801–1810
Fialova D, Topinkova E, Gambassi G, Finne-Soveri H, Jonsson PV, Carpenter I, Schroll M, Onder G, Sorbye LW, Wagner C, Reissigova J, Bernabei R (2005) Potentially inappropriate medication use among elderly home care patients in Europe. Jama 293(11):1348–1358
Lampela P, Hartikainen S, Lavikainen P, Sulkava R, Huupponen R (2010) Effects of medication assessment as part of a comprehensive geriatric assessment on drug use over a 1-year period: a population-based intervention study. Drugs Aging 27(6):507–521
Siegrist J, Shackelton R, Link C, Marceau L, von dem Knesebeck O, McKinlay J (2010) Work stress of primary care physicians in the US, UK and German health care systems. Soc Sci Med 71(2):298–304
Abteilung Gesundheit der VDEK (2011) Datenbestand Transparenzberichte in der DatenClearingStelle (5 Sept 2011). http://www.vdek.com/vertragspartner/Pflegeversicherung/Newsletter_Pflegenoten/DCS_2011-09-05.pdf. Accessed 8 Oct 2011.
Fahey T, Montgomery AA, Barnes J, Protheroe J (2003) Quality of care for elderly residents in nursing homes and elderly people living at home: controlled observational study. Bmj 326(7389):580
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lochner, S., Kirch, W. & Schindler, C. Managing hypertension among nursing-home residents and community-dwelling elderly in Germany: a comparative pharmacoepidemiological study. Eur J Clin Pharmacol 68, 867–875 (2012). https://doi.org/10.1007/s00228-011-1195-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-011-1195-0